Early Detection of Anaemia During the Maternity

Phase 3

Completed

• Conditions: Anemia
• Interventions: Biological: dosage of the NFS and iron

• Registration Number: NCT00827463
• Lead Sponsor: University Hospital, Limoges

Brief Summary

Estimate the efficiency of a strategy of premature screening of the maternal anaemia during the first quarter of pregnancy versus the usual strategy of screening of the anaemia during the sixth month.

Detailed Description

A part of the patient will have a NFS and dosage of the cast-iron, during the results of the beginning of the pregnancy at the first quarter.

The other part of the patients will have a NFS and at the first quater of the pregnancy.

All the patient will have a NFS at the results of the sixth month of the pregnancy.

A NFS will be done during the results at the end of the pregnancy like we do now.

Then a NFS at 48 hours after the birth. A treatment with iron will be done and according to the results

Study Timeline

• Study Start: 2009-01
• Study First Submitted: 2009-01-20
• Study First Submitted QC: 2009-01-21
• Study First Posted: 2009-01-22
• Status Verified: 2009-09
• Primary Completion: 2009-12
• Study Completion: 2009-12
• Last Update Submitted: 2016-08-19
• Last Update Posted: 2016-08-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

• Every patient followed at the HME at the beginnig of the pregnancy

Exclusion Criteria

• pregnency women who don't speak french
• pregnancy women affected by béta thalassemia
• pregnancy woman having had a périconceptionnel treatment against the anaemia

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
NFS and iron in the first quater	dosage of the NFS and iron	first arm: dosage NFS and iron during the beginning of the pregnancy then in the sixth month of pregnancy then in th delivery.
No NFS and iron in the first quater	dosage of the NFS and iron	second arm: dosage NFS and iron during the sixth month of pregnancy then in th delivery. No dosage of NFS and iron during the beginning of the pregnancy

Primary Outcome Measures

Name	Time	Method
primary outcomes: is the rate of heamophilia at the end of the pregnancy.	six months

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes: - the percent of treatment of intravenous irons during the pregnancy and the following layers. - the percent of transfusion and the following layers.	6 months

Trial Locations

Locations (1)

CHU limoges; 🇫🇷 Limoges, Limousin, France